Showing 711-720 of 1781 results for "".
Maximizing Safety and Efficacy of Colonoscopy Prep
https://reachmd.com/programs/gi-insights/maximizing-safety-and-efficacy-of-colonoscopy-prep/3245/Dr. Helen Shields, associate professor of medicine at Harvard Medical School, reviews key preparatory factors for a successful screening colonoscopy with host Dr. Jay Goldstein. Have we resolved recent controversies surrounding sodium phosphate preps? Beyond sodium phosphate, what alternatives can wCan What We Eat Lower Blood Pressure?
https://reachmd.com/programs/clinicians-roundtable/can-what-we-eat-lower-blood-pressure/3007/Dr. Lu Wang and her colleagues at Harvard Medical School have evaluated the eating habits of a large number of women in the Women’s Health Study and have shown an association between meat, grain and dairy intake and the development of hypertension. Dr. Wang will discuss some of the findings from theThe Adult Shingles Vaccine: Challenges of Delivery
https://reachmd.com/programs/clinicians-roundtable/the-adult-shingles-vaccine-challenges-of-delivery/2726/A vaccine for adult Shingles was officially licensed for use in 2006, but recent data shows that delivery of this vaccination has been a challenge. What are some of the issues which are limiting the distribution of the Shingles vaccine? How can we best address these difficulties? For expert insightGestational Diabetes--Treatment Works!
https://reachmd.com/programs/clinicians-roundtable/gestational-diabetes-treatment-works/1794/The list of maternal and neonatal morbidity from gestational diabetes is oppressive. Yet there is good evidence that aggressive glucose control can result in healthy outcomes that rival those of non-diabetic pregnancies. Our guest today is Doctor Thomas Moore. He is Professor and Chairman ofUtilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients
https://reachmd.com/programs/diabetes-discourse/utilizing-hybrid-closed-loop-technology-for-t1d-pediatric-patients/17885/Tune in to learn about a recent study on hybrid closed-loop technology in young children with type 1 diabetes.Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
https://reachmd.com/programs/medical-industry-feature/amyloid-tau-alzheimers-disease-progression/37874/The prevalence of dementia is projected to almost double every 20 years.1 Alzheimer’s disease (AD) is the most common cause of dementia,2 making early diagnosis and management increasingly important. Based on our current understanding of its pathology, AD is an amyloid driven tauopathy3 with biomarkDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
https://reachmd.com/programs/medical-industry-feature/depression-from-case-to-clinic-rethinking-partial-response-with-a-different-approach/54264/Many clinicians have seen a patient who’s had a partial response to antidepressants but is still struggling with the complexity of their depression. Because depression involves multiple biological systems, these therapies may not fully restore the biochemical balance needed for optimal neurotransmitRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
https://reachmd.com/programs/medical-industry-feature/rise-in-early-onset-colon-cancer-being-studied-through-single-cell-sequencing/29922/What’s behind the rise in colon cancer in younger patients? Listen to a breakdown of key trends, possible causes, and ongoing research to find answers.Utility of Stereoelectroencephalography in the Treatment of Drug-Resistant Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/utility-of-stereo-electroencephalography-in-the-treatment-of-drug-resistant-epilepsy/48919/Drug-resistant epilepsy, which affects about a third of people with epilepsy, can be effectively treated with epilepsy surgery, leading to seizure freedom in appropriately selected individuals.Discovering the Link Between GLP-1 Receptor Agonists and Weight Loss in Patients with HIV
https://reachmd.com/programs/clinicians-roundtable/discovering-the-link-between-glp-1-receptor-agonists-and-weight-loss-in-patients-with-hiv/16283/What were the key findings from a study on GLP-1 receptor agonists and weight loss in patients with HIV? Learn more.